Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Transcranial direct current stimulation for laryngeal dystonia

Official title: Network Targeted Transcranial Direct Current Stimulation (tDCS) as a Treatment for Laryngeal Dystonia (LD)

Run by Yale University · NCT06830174 · Data updated 2026-11-12

This trial will try transcranial direct current stimulation (tDCS) in people with laryngeal dystonia to see if it improves voice control.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorYale University
Academic / other
Locations1 site (New Haven, Connecticut)
StatusRecruiting
StartedApril 14, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedFebruary 9, 2026
Trial IDNCT06830174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a confirmed diagnosis of laryngeal dystonia who have no other speech or voice disorders, are not pregnant, and can attend multiple sessions at the study site are appropriate candidates.

Probably not a fit

People with a history of epilepsy or significant depression, those who are claustrophobic or pregnant, or those with other active voice disorders would likely be ineligible or unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will undergo baseline MRI and EEG recordings and then attend multiple testing sessions across five days. People with laryngeal dystonia will receive 20 minutes of high-definition tDCS (HD-tDCS) via the Starstim system while watching videos or performing a word-production task. Stimulation will be applied to several brain regions thought to be involved in voice control to alter neural activity. Outcomes will compare voice measures and neuroimaging/EEG signals before and after the stimulation protocol.

Why it matters

Potential benefit: If successful, this approach could reduce voice spasms and improve speech quality using a noninvasive, clinic-based treatment.

How similar studies have gone: Noninvasive brain stimulation methods like tDCS have produced mixed but promising findings in small studies of movement and voice disorders, so this approach is experimental but plausible.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must be clinically evaluated for the diagnosis of LD or have the proof of LD diagnosis. (Not applicable for control participants)
* No other known or history of speech, voice disorder other than LD.
* Provision of signed and dated informed consent form.
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Must not be pregnant.

Exclusion Criteria:

* All individuals who do not meet the above mentioned criteria are excluded from the study.
* Subjects with a history of epilepsy or depression or is claustrophobic.

Where it's running

  • Yale University
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.